Pharma Pli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The move is aimed at reducing Indian companies’ dependence on China for key chemicals needed to manufacture active pharmaceutical ingredients.

With large parts of the supply chain not falling under the schemes, domestic manufacturers face vulnerabilities.

In its year-end review, the Department of Pharmaceuticals (DoP) also said the 'Pradhan Mantri Bhartiya Janaushadhi Pariyojana' achieved its target of opening 10,000 retail outlets in 2023 to provide quality generic medicines at affordable prices to the poor and underprivileged.

The government has announced that investments totalling Rs 25,813 crore have been infused into the pharmaceutical sector, leading to the addition of 56,171 new jobs under the production-linked incentive scheme till September this year. In its year-end review, the Department of Pharmaceuticals (DoP) also highlighted the successful accomplishment of the 'Pradhan Mantri Bhartiya Janaushadhi Pariyojana,' meeting its goal of establishing 10,000 retail outlets in 2023.

Govt approves 33 API applications with over Rs 5,000 cr committed investment under PLI scheme Synopsis Department of Pharma has launched a PLI scheme for the promotion of domestic manufacturing by setting up greenfield plants in four different target segments with a total outlay of Rs 6,940 crore for the period 2020-21 to 2029-30. In total, 215 applications have been received for the 36 products spread across the 4 target segments, the Ministry of Chemicals and Fertilizers said in the release. The government has approved a total of 33 applications with a committed investment of Rs 5,082.65 cr...